West Pharmaceutical Services (WST) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does West Pharmaceutical Services (WST) do?
West Pharmaceutical Services Inc (WST) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Manufactures rubber stoppers, seals, and containment components for injectable medications and vaccines. Produces specialized rubber stoppers and packaging components for injectable medicines across the pharmaceutical. It is worth $27.63B on the market and sold $3.40B over the last year.
- Market cap
- $27.63B
- P/E ratio
- 44.5×
- Annual sales
- $3.40B
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Brief updated
- Nov 08, 2026
Brands and businesses behind WST
- NovaPure: Supplies high-purity elastomer stoppers and plunger components designed to protect sensitive biologic medications from contamination.
- SmartDose: Produces wearable electronic injector systems that deliver high-volume injectable therapies subcutaneously to patients.
WST’s flags, in plain English
Each flag is a number from West Pharmaceutical Services’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 08, 2026.
Stupid Cash
Can pay this year's bills 2.8 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Low debt
Low debt, only 11% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Capital Works Hard
Earns 19.6% a year on the money it invests in the business. The money in the business, from shareholders and lenders together, earns a strong return. That points to a company that picks its investments well.
Priced for Perfection
Priced at 44.5 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about WST
How big is West Pharmaceutical Services?
West Pharmaceutical Services’ market cap is $27.63B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.40B: what customers paid the company over the last year, before any costs.
What is WST’s P/E ratio?
WST’s P/E ratio is 44.5×. Investors pay about 44.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with WST?
Customer inventory destocking following periods of high vaccine and drug production creates volatility in component order volumes. That is one risk on West Pharmaceutical Services’ card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From West Pharmaceutical Services’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. WST’s filings on SEC.gov. The Margin Monkey is research, not advice.
